Literature DB >> 475736

Long term effects of the anorectic agent fenfluramine alone and in combination with aminorex on pulmonary and systemic circulation in the pig.

J Mlczoch, E K Weir, J T Reeves, R F Grover.   

Abstract

We have investigated the effects of chronic oral administration of two anorectic substances, fenfluramine and aminorex, especially on the pulmonary circulation in young pigs with one ligated pulmonary artery. The pulmonary vascular reactivity was tested by alveolar hypoxia, alveolar hyperoxia and infusion of prostaglandin F2ALPHA. No elevation of pulmonary arterial pressures or resistances were found due to the intake of fenfluramine or aminorex over a three month period. The responses to the vasoconstrictor stimuli, hypoxia and prostaglandin F2alpha, and to the vasodilator stimulus, hyperoxia, were equal and not augmented in the drug groups. Fenfluramine or aminorex could therefore could therefore not be shown to have an adverse effect on the pulmonary circulation or on the reactivity of the pulmonary vascular bed in the pig, but fenfluramine elevated systemic arterial pressure.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 475736     DOI: 10.1007/bf01907748

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  15 in total

Review 1.  [Primary pulmonary hypertension].

Authors:  F Loogen; A Both
Journal:  Z Kardiol       Date:  1976-01

2.  The effect of increased pulmonary blood flow on the pulmonary vascular bed in pigs.

Authors:  B Friedli; G Kent; B S Kidd
Journal:  Pediatr Res       Date:  1975-06       Impact factor: 3.756

3.  RIGHT VENTRICULAR HYPERTROPHY IN ANIMALS AT HIGH ALTITUDE.

Authors:  H N HULTGREN; E MARTICORENA; H MILLER
Journal:  J Appl Physiol       Date:  1963-09       Impact factor: 3.531

Review 4.  Dietary pulmonary hypertension.

Authors:  A P Fishman
Journal:  Circ Res       Date:  1974-11       Impact factor: 17.367

5.  Ligation of a single pulmonary artery in the pig: a model of chronic pulmonary hypertension.

Authors:  J G Rosenkrantz; J H Carlisle; F P Lynch; J H Vogel
Journal:  J Surg Res       Date:  1973-07       Impact factor: 2.192

6.  Effects of anorectic agents on blood pressure of the dog.

Authors:  S E Bocknik; A S Kulkarni
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-04

7.  [Relation between serotonin metabolism and pulmonary hypertension in rats following administration of various anorectic drugs].

Authors:  H Mielke; K U Seiler; U Stumpf; O Wassermann
Journal:  Z Kardiol       Date:  1973-12

8.  Aminorex and the pulmonary circulation.

Authors:  J M Kay; P Smith; D Heath
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

9.  On-line cardiac output by digital computer.

Authors:  F Huber; I E Sodal; J V Weil
Journal:  J Appl Physiol       Date:  1976-02       Impact factor: 3.531

10.  Lung vascular smooth muscle as a determinant of pulmonary hypertension at high altitude.

Authors:  A Tucker; I F McMurtry; J T Reeves; A F Alexander; D H Will; R F Grover
Journal:  Am J Physiol       Date:  1975-03
View more
  3 in total

Review 1.  A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Authors:  Jose Gomez-Arroyo; Sheinei J Saleem; Shiro Mizuno; Aamer A Syed; Harm J Bogaard; Antonio Abbate; Laimute Taraseviciene-Stewart; Yon Sung; Donatas Kraskauskas; Daniela Farkas; Daniel H Conrad; Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

2.  Drug-induced pulmonary arterial hypertension: a primer for clinicians and scientists.

Authors:  Mark E Orcholski; Ke Yuan; Charlotte Rajasingh; Halley Tsai; Elya A Shamskhou; Navneet K Dhillon; Norbert F Voelkel; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-08       Impact factor: 5.464

Review 3.  DARK Classics in Chemical Neuroscience: Aminorex Analogues.

Authors:  Julian Maier; Felix P Mayer; Simon D Brandt; Harald H Sitte
Journal:  ACS Chem Neurosci       Date:  2018-10-05       Impact factor: 5.780

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.